Adial Pharmaceuticals (ADIL) announced patent number 12,226,401 was issued on February 18, 2025 by the United States Patent and Trademark ...
Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...
A new patent has been published in the US that sounds very similar to one of the Japanese patents which Pocketpair was alleged to have infringed upon in Nintendo's ongoing lawsuit against the ...
Spectrum Solutions LLC successfully defended on appeal a district court ruling that its home saliva-collection kits for Covid-19 testing don’t infringe a DNA Genotek Inc. patent.
KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...
United States patent number 6,469 is for "buoying vessels over shoals." Granted on May 22, 1849, the concept involves equipping large boats with "india-rubber cloth, or another suitable waterproof ...
A Nintendo Switch 2 patent suggests you will be able to plug in the Joy-Con controllers upside down This would cause the image on its display to flip The patent suggests this could allow users to ...
A US district court has said that a key patent held by Astellas on its Myrbetriq drug for urinary incontinence is invalid, in a setback to its efforts to defend the blockbuster therapy from ...
Fudan University has disclosed phosphatidylcholine:ceramide cholinephosphotransferase 2 (SGMS2; SMS2) inhibitors reported to be useful for the treatment of cancer, atherosclerosis, dry eye, pulmonary ...
Judge Declines to Block Musk From Accessing Agency Records or Ordering Firings Musk team’s next target is probationary Pentagon employees. Patel clears a procedural hurdle in the Senate, putting ...
The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...